BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34068281)

  • 1. Apigenin and Luteolin Regulate Autophagy by Targeting NRH-Quinone Oxidoreductase 2 in Liver Cells.
    Janda E; Martino C; Riillo C; Parafati M; Lascala A; Mollace V; Boutin JA
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34068281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of proautophagic activities of Citrus flavonoids in liver cells reveals the superiority of a natural polyphenol mixture over pure flavones.
    Lascala A; Martino C; Parafati M; Salerno R; Oliverio M; Pellegrino D; Mollace V; Janda E
    J Nutr Biochem; 2018 Aug; 58():119-130. PubMed ID: 29890411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of NQO2 on the dysfunctional autophagy and oxidative stress induced in the hippocampus of rats and in SH-SY5Y cells by fluoride.
    Ran LY; Xiang J; Zeng XX; He WW; Dong YT; Yu WF; Qi XL; Xiao Y; Cao K; Zou J; Guan ZZ
    CNS Neurosci Ther; 2023 Apr; 29(4):1129-1141. PubMed ID: 36650666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
    Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
    Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson's disease.
    Janda E; Parafati M; Martino C; Crupi F; George William JN; Reybier K; Arbitrio M; Mollace V; Boutin JA
    Sci Rep; 2023 Dec; 13(1):21624. PubMed ID: 38062122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM; Tran N; Knox R; Jaiswal AK
    Biochem Pharmacol; 2006 Jul; 72(3):366-76. PubMed ID: 16765324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms and Pharmacogenomics of
    Janda E; Boutin JA; De Lorenzo C; Arbitrio M
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors.
    Lozinskaya NA; Bezsonova EN; Dubar M; Melekhina DD; Bazanov DR; Bunev AS; Grigor'eva OB; Klochkov VG; Sokolova EV; Babkov DA; Spasov AA; Sosonyuk SE
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme.
    Janda E; Nepveu F; Calamini B; Ferry G; Boutin JA
    Mol Pharmacol; 2020 Nov; 98(5):620-633. PubMed ID: 32913139
    [No Abstract]   [Full Text] [Related]  

  • 13. NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis.
    Dorai T; Shah A; Summers F; Mathew R; Huang J; Hsieh TC; Wu JM
    Prostate; 2018 Nov; 78(15):1181-1195. PubMed ID: 30009389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity.
    Long DJ; Iskander K; Gaikwad A; Arin M; Roop DR; Knox R; Barrios R; Jaiswal AK
    J Biol Chem; 2002 Nov; 277(48):46131-9. PubMed ID: 12351651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue.
    Strassburg A; Strassburg CP; Manns MP; Tukey RH
    Mol Pharmacol; 2002 Feb; 61(2):320-5. PubMed ID: 11809856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction.
    Wang W; Jaiswal AK
    Free Radic Biol Med; 2006 Apr; 40(7):1119-30. PubMed ID: 16545679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRH:quinone oxidoreductase2 (NQO2).
    Long DJ; Jaiswal AK
    Chem Biol Interact; 2000 Dec; 129(1-2):99-112. PubMed ID: 11154737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
    Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumol Overcomes TRAIL Resistance of Non-Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2).
    Zhang J; Zhou Y; Li N; Liu WT; Liang JZ; Sun Y; Zhang WX; Fang RD; Huang SL; Sun ZH; Wang Y; He QY
    Adv Sci (Weinh); 2020 Nov; 7(22):2002306. PubMed ID: 33240775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.